Jan.31 — Mark Emalfarb, Dyadic International chief executive officer, discusses the efforts to find a vaccine for the deadly coronavirus. He speaks with Bloomberg’s Taylor Riggs on “Bloomberg Technology.”
In This Story: Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.